Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
Recruiting · NCT06749054 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children | HIV-1-infection | Recruiting | Phase 2 | 2026-04-24 | NCT06749054 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Be Part Research Pty (Ltd) | Paarl | South Africa | 1 |
| Clinical Research Institute of South Africa (CRISA) | KwaDukuza | South Africa | 2 |
| CRISMO Research Centre | Germiston | South Africa | 1 |
| FAMCRU | Cape Town | South Africa | 1 |
| Grady Health System, Ponce De Leon Center | Atlanta | United States | 1 |
| Perinatal HIV Research Unit (PHRU) | Soweto | South Africa | 2 |
| Rahima Moosa Mother and Child Hospital | Johannesburg | South Africa | 3 |
| Wits RHI Shandukani Research Centre CRS | Johannesburg | South Africa | 2 |